Bahrain has approved the Sinopharm COVID-19 vaccine for children aged between 3 and 11 years, from October 27.
The country's National Medical Taskforce for Combatting the Coronavirus said the decision was taken following a thorough review of all health and safety recommendations.
It also added that the Pfizer COVID-19 vaccine would soon be approved for children between 5 and 11.
The Taskforce stressed that it is important that eligible children get vaccinated to protect themselves, their families, and public health.
Parents can register their children through the Ministry of Health's website or through the BeAware application.
Registration requires the consent of a legal guardian and an adult must accompany the child when receiving the vaccine.
Sinopharm vaccine approved for all children aged 3 to 11https://t.co/AwEJ2fBddb
— Bahrain News Agency (@bna_en) October 26, 2021
Trump postpones military strikes on Iranian power plants
Pilot, co-pilot killed after passenger jet hits fire truck at LaGuardia airport
Kuwait launches probe into espionage, state security cases
Trump, Iran threaten to escalate conflict with attacks on energy and water facilities
Fuel reservoir in Russia's Primorsk port on fire after drone attack, governor says
Ambulances from Jewish community organisation torched, UK police say
Israeli airstrikes kill four in Gaza, Palestinian officials say
Iran says Hormuz open to all but ‘enemy-linked’ ships
